Rubius Therapeutics Inc logo

Rubius Therapeutics Inc

FRA:5RT (USA)  
€ 0.01 (-23.53%) Mar 15
At Loss
Market Cap:
€ 1.62M ($ 1.73M)
Enterprise V:
€ -15.23M ($ -16.22M)
Volume:
-
Avg Vol (2M):
-

Business Description

Description
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
6-1 Month Momentum % -79.43
12-1 Month Momentum % -93.39

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
EV-to-Forward-Revenue 5.17

Financials (Next Earnings Date:2024-05-10 Est.)

FRA:5RT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rubius Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -1.906
Beta 0
Volatility % 107.09
14-Day RSI 0
14-Day ATR (€) 0.011571
20-Day SMA (€) 0
12-1 Month Momentum % -93.39
52-Week Range (€) 0.013 - 5.35
Shares Outstanding (Mil) 90.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rubius Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Rubius Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Rubius Therapeutics Inc Frequently Asked Questions

What is Rubius Therapeutics Inc(FRA:5RT)'s stock price today?
The current price of FRA:5RT is €0.01. The 52 week high of FRA:5RT is €5.35 and 52 week low is €0.01.
When is next earnings date of Rubius Therapeutics Inc(FRA:5RT)?
The next earnings date of Rubius Therapeutics Inc(FRA:5RT) is 2024-05-10 Est..
Does Rubius Therapeutics Inc(FRA:5RT) pay dividends? If so, how much?
Rubius Therapeutics Inc(FRA:5RT) does not pay dividend.

Press Release

Subject Date
No Press Release